ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Gross margin 2022–2025
ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) gross margin by fiscal year — reported gross profit divided by reported revenue.
90.2%FY2025 · since FY2022: 79.5% → 90.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 90.2% | -0.0 pp |
| FY2024 | 90.3% | -1.4 pp |
| FY2023 | 91.6% | +12.1 pp |
| FY2022 | 79.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice